CO2 production after suxamethonium and diazepam

Area of Science:

• Anesthesiology
• Pharmacology
• Surgical Research

Background:

• Suxamethonium is a muscle relaxant used in anesthesia.
• Its administration can cause side effects like fasciculations and muscle pain.
• Carbon dioxide (CO2) production is a physiological marker that can be affected by anesthetic agents.

Purpose of the Study:

• To investigate the effect of increasing doses of suxamethonium on CO2 production.
• To evaluate the potential of diazepam to mitigate the CO2 production associated with suxamethonium.
• To explore the prophylactic use of diazepam against suxamethonium-induced side effects.

Main Methods:

• CO2 production and muscle relaxation were measured in patients undergoing hip surgery.
• Patients received escalating doses of suxamethonium.
• A separate group received diazepam prior to suxamethonium administration.

Main Results:

• Suxamethonium administration led to a dose-dependent increase in CO2 production.
• Pre-treatment with diazepam (0.1 mg kg-1) significantly reduced CO2 production compared to suxamethonium alone.
• This suggests a potential interaction between diazepam and suxamethonium's physiological effects.

Conclusions:

• Diazepam may attenuate the increase in CO2 production caused by suxamethonium.
• Higher doses of diazepam could potentially prevent suxamethonium-induced fasciculations and postoperative muscle pain.
• Further research is warranted to confirm the optimal prophylactic dosage of diazepam.